Adult-onset Still’s disease in a 73-year-old Maltese man
- 1 Department of Medicine, Mater Dei Hospital, Msida, Malta
- 2 Department of Rheumatology, Mater Dei Hospital, Msida, Malta
- Correspondence to Dr Janice Borg; janice.c.borg@gov.mt
Abstract
Adult-onset Still’s disease (AOSD) is a rare autoinflammatory condition diagnosed by Yamaguchi criteria. We report an atypical presentation of a 73-year-old man, who was admitted with fever, sore throat and pleurisy that were unresponsive to three courses of antibiotics. Fever persisted in a quotidian pattern and the typical salmon-coloured rash consistent with AOSD appeared at 4 weeks from symptoms onset. These features in addition to neutrophilia and hyperferritinaemia in the absence of concurrent infectious and neoplastic causes satisfied Yamaguchi criteria for a diagnosis of AOSD. Epstein-Barr antigen was initially detected at moderate titre levels, but was undetectable after 1 week. Complete resolution of symptoms was reported on initiation of steroid treatment. A relationship between disease onset and viral syndromes has been documented to occur and few similar cases preceded by Epstein-Barr virus detection have been reported.
Background
Adult-onset Still’s disease (AOSD) is a rare polygenic, systemic autoinflammatory condition, which is reported in 1.6 cases/million1 and tends to predominate in two main age groups: 16–26 years and 36–46 years. Despite its rarity outside this age group, we report a case of an elderly man who presented with AOSD symptoms preceded by the occurrence of Epstein-Barr virus (EBV), which responded immediately to low-dose steroids. Despite that concomitant infection precludes the diagnosis of AOSD according to Yamaguchi criteria,2 there are various case reports identifying a viral trigger preceding the onset of classical symptoms.
Case presentation
A 73-year-old Maltese man presented with a 3-day history of fever up to 39°C, associated with a 1-week history of sore throat and cough productive of green sputum. He denied any rashes, joint pains and oral ulcers. In addition, he also reported an unintentional weight loss of 8 kg over the previous 2 weeks. His medical history included thalassaemia trait and renal colic. His surgical history and drug history were unremarkable. He was a lifelong non-smoker and denied drug use or regular alcohol intake. He did not report any recent travel. Family history, including a history of malignancy, was unremarkable. No close contact members were similarly affected.
On clinical assessment, the patient was afebrile with stable parameters. Full physical examination, including chest examination, was normal. At this point, a provisional diagnosis of a lower respiratory tract infection was made and he was discharged on oral antibiotics.
Few days later, he returned to the emergency department with persistent quotidian fever, highest in the evenings reaching up to 39°C. Four weeks into the disease course, the patient reported increasing malaise, myalgias and arthralgias involving bilateral shoulders, hips, hands and wrists. A diffuse salmon-coloured non-pruritic coalescent maculopapular rash developed a few days after, which intensified during febrile episodes and settled after 48 hours.
Investigations
On presentation, blood investigations revealed a raised white cell count (80% neutrophils), microcytic anaemia with a haemoglobin (Hb) of 95 g/L and mean cell volume (MCV) of 59.3 fL (79–93 fL). Blood film showed longstanding microcytic hypochromic anaemia in keeping with haemoglobinopathy and reactive neutrophils with no immature granulocytes. C reactive protein (CRP) of 206 mg/L (0–5 mg/L) and erythrocyte sedimentation rate of 50 mm first hour (28–32 mm first hour). Liver function tests (LFTs) and chest X-ray were normal.
A respiratory screen tested positive for Staphylococcus aureus, and though EBV viral capsid antigen (VCA) IgM, VCA IgG and nuclear antigen-1 IgG were negative, Epstein-Barr antigen was detected by PCR at 6747 copies/mL. The rest of the septic screen was negative, including blood and urine cultures and viral and bacterial screens for Cytomegalovirus (CMV), parvovirus, HIV, Mycoplasma and Legionella. Immunology testing, including Rheumatoid Factor (RhF), antinuclear antibodies (ANA), antineutrophil cytoplasmic antibodies, anti-cyclic citrullinated peptide and immunoglobulins were all negative. A multiple myeloma screen, including serum protein electrophoresis (SPE) and serum free light chains (SFLC), was negative. Transthoracic and transoesophageal echocardiograms ruled out the possibility of infective endocarditis.
Repeat LFTs during the second admission revealed a mildly deranged mixed picture with alanine aminotransferase (ALT) of 72 U/L (5–41 U/L), alkaline phosphatase (ALP) of 180 U/L (40–129 U/L) and gamma-glutamyl transferase (GGT) of 76 U/L (8–61 U/L). Haematinics, including vitamin B12, folate and iron profile, were unremarkable except for an elevated ferritin of 3028 ng/mL (22–322 ng/mL), later rising further to 12 868 ng/mL. Lactate dehydrogenase was minimally raised (359 U/L (135–220 U/L)). The patient subsequently developed symptomatic anaemia (Hb of 7.0 g/dL) that required transfusion of red cell concentrate. A full summary of relevant blood investigations is outlined in table 1.
Summary of laboratory parameters
Laboratory parameters | First presentation | Second presentation | After following the initiation of prednisolone treatment |
White blood cell count, 109/L | 17.94 | 13.4 | 9.63 |
Neutrophil count, 109/L | 15.4 | 10.48 | 2.83 |
Haemoglobin, g/L | 98 | 75 | 93 |
Mean cell volume, fL | 59.7 | 56.6 | 60.5 |
Platelets, 109/L | 300 | 632 | 435 |
LDH, U/L | 359 | N/A | N/A |
CRP, mg/L | 282 | 180 | 76.1 |
ESR, mm first hour | 50 | 108 | 8 |
Liver profile | |||
ALT, U/L | 19 | 72 | 10 |
ALP, U/L | 94 | 126 | 68 |
YGT, U/L | 29 | 51 | 19 |
Bilirubin, µmol/L | 9.6 | 4.2 | 10.9 |
Ferritin, ng/mL | 3028 | 12 868 | 312 |
Viral PCR | |||
Epstein-Barr antigen (copies/mL) | 6747 | Not detected | Not detected |
-
ALP, alkaline phosphatase; ALT, Alanine aminotransferase; CRP, C reactive protein; ESR, erythrocyte sedimentation rate; GGT, gamma-glutamyl transferase; LDH, lactate dehydrogenase.
Plain X-rays performed for arthralgias excluded any evidence of bone pathology and the absence of synovitis or tendinitis were confirmed on ultrasonography of the hands and wrists. CT of the thorax, abdomen and pelvis showed non-specific bilateral small pleural effusions not amenable for tapping and a small pericardial effusion. An MRI of the whole spine was performed in view of intermittent non-limiting back pain, which showed only osteoarthritic changes. This modality was selected over myelography as it is less invasive, and no contraindications were present. Following this, a positron emission tomography–computed tomography (PET-CT) was then performed, which excluded malignant processes and systemic vasculitides. Repeated respiratory screen and Epstein-Barr antigen PCR after 1 week turned negative.
Differential diagnosis
This case described a healthy elderly man who presented with initial symptoms of a lower respiratory tract infection, in addition to a significant 8 kg weight loss over a span of 2 weeks. Given the initial presenting features, a bacterial lower respiratory tract infection was the primary provisional diagnosis and was, therefore, prescribed antibiotics. However, despite treatment, the patient returned with persistent high-grade quotidian fevers, which were unresponsive to further antibiotic treatment.
Given the history of significant weight loss on presentation, the possible diagnosis of an underlying haematological and solid organ tumour were excluded through CT of the thorax, the abdomen and the pelvis. Multiple myeloma was excluded through normal SPE and SFLC and an MRI of the whole spine. Furthermore, a PET scan was performed, which further excluded any underlying malignancy, which was possibly missed on other radiological investigations. There was no indication for a bone marrow aspirate or trephine in this case given that there was no evidence of haematological malignancies on intensive biochemical and radiological investigations and the patient satisfied the Yamaguchi criteria for a diagnosis of AOSD.
The possibility of EBV-related prolonged viral infection was raised following the detection of EBV viral load via PCR. However, this case did not fulfil criteria neither for protracted course of infectious mononucleosis (IM) nor for chronic active EBV infection and had tested negative on repeat tests.
Other EBV-associated diseases include malignancies (Burkitt’s and Hodgkin’s lymphoma, and nasopharyngeal carcinoma), which were excluded following a thorough investigation. Autoimmune diseases are also described, and these include Sjögren’s syndrome, rheumatoid arthritis and systemic lupus erythematosus,3 but in the presented case, there were neither the symptoms nor repeat immunology testing present to satisfy any such criteria.
Four weeks into the disease, the patient developed arthralgia and a typical diffuse salmon-coloured non-pruritic rash, which in addition to fever of 39°C for at least 1 week, granulocytic leucocytosis, abnormal LFTs and negative tests for RhF and ANA satisfied the Yamaguchi criteria for a diagnosis of AOSD.
Treatment
Initially, the patient was treated with a 7-day course of co-amoxiclav (1.2 g three times per day intravenously for 4 days, then changed to an oral dose of 1 g two times per day for another 3 days) with no beneficial effect. This was followed by oral doxycycline (200 mg stat day one followed by 100 mg two times per day) for a total of 10 days, and piperacillin/tazobactam (4.5 g three times per day) for another 7 days also to poor effect. Once Yamaguchi criteria was satisfied, antibiotic treatment was stopped and oral prednisolone (40 mg/day) was initiated at 0.5 mg/kg/day.
Outcome and follow-up
There was immediate resolution of symptoms on initiation of prednisolone with significant biochemical improvement in the following days (table 1). The patient regained independence since arthralgias resolved. The patient was given a tailing down regiment of prednisolone with an outpatient follow-up appointment in 3 months. On review at the outpatient clinic, the patient had remained very well, completely asymptomatic with no further febrile episodes or recurrence of rash.
Discussion
AOSD mainly affects young adults, with higher prevalence in women and an incidence rate of 0.16 per 100 000 individuals. It has a bimodal age distribution with peaks at 15–25 years and 36–46 years of age.1 The clinical presentation of AOSD is heterogeneous, and the spectrum of differential diagnoses is broad. The diagnosis of AOSD is made through a combination of clinical and laboratory findings and exclusion of infectious, neoplastic or other autoinflammatory conditions.
We present a case of fever of unknown origin in an elderly man, which fulfilled the necessary criteria according to Yamaguchi et al for the diagnosis of AOSD (table 2). Five or more criteria are required, of whom two or more must be major. A second criteria by Fautrel et al 4 was proposed in 2002 (table 2), which proved to be more specific (98.5% vs 93.8%) with fewer false positive cases. AOSD is confirmed if four major criteria or three major and two minor are satisfied. Its specificity was attributed to the use of glycosylated ferritin, an isoform of serum ferritin, instead of serum ferritin and as a result, exclusion criteria are not required.
Yamaguchi and Fautrel criteria
Major criteria | Minor criteria | |
Yamaguchi criteria | Fever of at least 39°C for at least 1 week | Sore throat |
Arthralgia or arthritis for at least 2 weeks | Lymphadenopathy | |
Non-pruritic salmon-coloured rash on trunk/extremities | Hepatomegaly or ssplenomegaly | |
Granulocytic leucocytosis (>80% neutrophils) | Abnormal liver function tests | |
Negative tests for rheumatoid factor and antinuclear antibodies | ||
Spiking fever ≥39°C | Maculopapular rash | |
Arthralgia | Leucocytes ≥10 x109/L | |
Transient erythema | ||
Fautrel criteria | Pharyngitis | |
PMN ≥80% | ||
Glycosylated ferritin ≤20% |
-
PMN, Polymorphonuclear leukocytes.
There are, however, few cases reporting AOSD in the elderly, with a high propensity among Asian people.5–10
The aetiology of AOSD is still unclear but it is believed to occur as an interplay between genetic component, linked to human leucocyte antigen (HLA) alleles, and infectious triggers, which initiate an immune response characterised by the production of various interleukins (ILs), including IL-1, IL-6, IL-18, interferon-γ and tumour necrosis factor alpha.11 12 A temporal relationship between disease onset and viral or bacterial syndromes is documented to occur with parvovirus B19, rubella virus, mumps, echovirus 7, human herpes virus 6, parainfluenza virus, EBV, CMV, coxsackievirus B4 and adenovirus.13
However, distinguishing acute triggering infection from long-lasting infection with chronic persistence of the infectious agent is challenging.12 Anderson et al describes an AOSD presentation having elevated coxsackie B viral antibody titres twice during the disease course, mostly associated with disease flare, which later decreased after treatment administration.14 Similarly, CMV DNA was found to positively correlate with the leucocyte count and inflammatory markers in AOSD patients, neutrophils being the driving force and initiating monocyte activation leading to the cascade of inflammatory pathway. Levels of anti-CMV IgM and IgG antibodies have been shown to be higher in AOSD patients when compared with controls, and higher values were found in patients with new-onset and relapsing AOSD.15
Cases of AOSD preceded by EBV detection have also been reported.16 17 This correlation may be ascribed to the fact that patients may harbour segments in the polymorphic region of their HLA molecules that are homologous to EBV glycoprotein 110.18 This has also been hypothesised in association with rheumatoid arthritis19 and oligoarticular juvenile idiopathic arthritis.20
Different techniques have been used to determine the presence of EBV DNA and measuring the viral load, including dot blotting, Southern blotting, PCR and in situ hybridisation. EBV DNA by PCR may be more sensitive than serology in early stages of primary infection or reactivation of EBV because VCA IgM may not be produced or produced at low levels unable to be detected. EBV DNA can be detected after 2 weeks from onset of symptoms and rapidly decline by 3–4 weeks, becoming undetectable in plasma/serum.21 The unlikelihood of detectable EBV DNA in the absence of EBV disease was identified. EBV DNA is highly sensitive to disease occurance. A study done by Kankry et al showed that patients with active systemic EBV infection had a median EBV DNA of 14 783 copies/mL when compared to patients with EBV infection in remission or absent infection, in whom the EBV DNA were 0 copies/mL. 22
A protracted course of IM in our patient was unlikely. First, repeated EBV DNA after 5 days was negative, corresponding to the time frame of EBV DNA persistence during acute infection. In addition, although mild liver transaminases can occur in both IM and AOSD, deranged LFTs occurred in the second admission, 4 weeks after initial presentation. Lastly, the patient had anaemia requiring red blood cell transfusion, which is more likely in AOSD rather than IM. On the other hand, chronic active EBV infection can be misdiagnosed as AOSD,23 and often leading to life-threatening complications and haematological malignancies. Our case did not satisfy the diagnostic criteria of chronic active EBV infection, which is shown in table 3.24 25
Diagnostic criteria of chronic active EBV infection. All criteria must be fulfilled
Diagnostic criteria of chronic active EBV infection | |
1 | Sustained or recurrent IM-like symptoms persist for more than 3 months |
2 | Elevated EBV genome load in the peripheral blood or the tissue lesion |
3. | EBV infection of T or NK cells in the affected tissues or the peripheral blood |
4. | Exclusion of other possible diagnoses: primary infection of EBV, autoimmune diseases, congenital immunodeficiencies, HIV and other immunodeficiencies requiring immunosuppressive therapies or underlying diseases with potential immunosuppression |
5. | Sustained or recurrent IM-like symptoms persist for more than 3 months |
-
EBV, Epstein-Barr virus; IM, infectious mononucleosis; NK cells, Natural killer cells.
Learning points
-
Adult-onset Still’s disease (AOSD) tends to have a bimodal age distribution with peaks at 15–25 years and 36–46 years of age; however, it should be kept in mind that it can occur at any age.
-
A diagnosis of AOSD is made through clinical and laboratory findings with exclusion of other infectious, autoimmune or neoplastic conditions.
-
A second criteria had been introduced by Fautrel et al in 2002 (table 2), which has been shown to be more specific than Yamaguchi criteria (98.5% vs 93.8%) with fewer false positive cases.
-
Among other possible interplaying factors, infectious trigger has been proposed as a potential mechanism for the development of AOSD activation of an immune response as in our case.
-
Distinguishing AOSD from a prolonged viral illness with chronic persistence can be challenging in such cases.
Footnotes
-
Contributors All authors contributed to the care of the patient and the planning and reporting of the work. JB wrote the case report and carried out the preparation and the write up for the discussion. MLC critically appraised the case report and was also involved in the literature review. PJC was the patient’s caring consultant who also reviewed the case report prior to publication.
-
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
-
Competing interests None declared.
-
Patient consent for publication Obtained.
-
Provenance and peer review Not commissioned; externally peer reviewed.
- © BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.
References
Use of this content is subject to our disclaimer